Fideuram Intesa Sanpaolo Private Banking S.P.A. Invests $8.91 Million in CVS Health Corporation $CVS

Fideuram Intesa Sanpaolo Private Banking S.P.A. acquired a new position in CVS Health Corporation (NYSE:CVS) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 112,237 shares of the pharmacy operator’s stock, valued at approximately $8,907,000.

A number of other large investors have also recently made changes to their positions in the business. PNC Financial Services Group Inc. grew its position in shares of CVS Health by 5.4% in the 4th quarter. PNC Financial Services Group Inc. now owns 585,322 shares of the pharmacy operator’s stock worth $46,451,000 after buying an additional 30,035 shares during the last quarter. Larson Financial Group LLC lifted its stake in shares of CVS Health by 17.5% in the 4th quarter. Larson Financial Group LLC now owns 5,634 shares of the pharmacy operator’s stock valued at $447,000 after purchasing an additional 839 shares during the period. Handelsbanken Fonder AB lifted its stake in shares of CVS Health by 0.5% in the 4th quarter. Handelsbanken Fonder AB now owns 594,271 shares of the pharmacy operator’s stock valued at $47,161,000 after purchasing an additional 2,860 shares during the period. McKinley Carter Wealth Services Inc. purchased a new position in shares of CVS Health in the 4th quarter valued at approximately $203,000. Finally, Profund Advisors LLC lifted its stake in shares of CVS Health by 26.1% in the 4th quarter. Profund Advisors LLC now owns 20,651 shares of the pharmacy operator’s stock valued at $1,639,000 after purchasing an additional 4,279 shares during the period. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Down 1.9%

CVS stock opened at $94.18 on Wednesday. CVS Health Corporation has a 1-year low of $58.50 and a 1-year high of $98.43. The business has a fifty day moving average price of $79.39 and a 200-day moving average price of $78.76. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.87 and a quick ratio of 0.66. The stock has a market capitalization of $120.16 billion, a P/E ratio of 41.49, a P/E/G ratio of 0.94 and a beta of 0.60.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share for the quarter, topping the consensus estimate of $2.21 by $0.36. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The firm had revenue of $100.43 billion during the quarter, compared to analysts’ expectations of $94.99 billion. During the same quarter in the previous year, the business earned $2.25 earnings per share. The company’s revenue was up 6.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. Equities analysts forecast that CVS Health Corporation will post 7.44 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, May 4th. Stockholders of record on Thursday, April 23rd were paid a $0.665 dividend. The ex-dividend date was Thursday, April 23rd. This represents a $2.66 annualized dividend and a dividend yield of 2.8%. CVS Health’s payout ratio is currently 117.18%.

Insider Buying and Selling at CVS Health

In other news, EVP Tilak Mandadi sold 69,551 shares of the business’s stock in a transaction on Friday, May 8th. The stock was sold at an average price of $89.58, for a total value of $6,230,378.58. Following the completion of the transaction, the executive vice president owned 10,133 shares in the company, valued at $907,714.14. The trade was a 87.28% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.85% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. Robert W. Baird raised their target price on CVS Health from $92.00 to $94.00 and gave the company an “outperform” rating in a research note on Wednesday, April 15th. Wall Street Zen upgraded CVS Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. UBS Group raised their target price on CVS Health from $97.00 to $100.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. Truist Financial raised their target price on CVS Health from $98.00 to $102.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. Finally, Sanford C. Bernstein raised their target price on CVS Health from $94.00 to $106.00 and gave the company an “outperform” rating in a research note on Tuesday, May 12th. Twenty-two investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $98.08.

More CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS Health and WGU launched an online pre-pharmacy degree program aimed at building a pipeline of future pharmacists nationwide, which could help address labor shortages and support CVS’s retail pharmacy operations. CVS Health(R) and WGU Launch Online Pre-Pharmacy Degree Program for Future Pharmacists Nationwide
• Positive Sentiment: CVS also backed EnsembleIQ’s campaign supporting retail pharmacy as a way to help fill healthcare gaps, reinforcing CVS’s role in community pharmacy and care access. EnsembleIQ’s DSN, a Trusted Source in the Community Pharmacy Space, Launches Campaign in Support of Retail Pharmacy Filling Health Care Gaps
• Positive Sentiment: CVS Health published a study showing many Medicare members struggle with digital health literacy, which supports the company’s push to invest in digital tools and member engagement. CVS Health study reveals a need for greater digital health literacy for Medicare members

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.